Mike Hurwitz, MD, PhD
Yale Cancer Center
Yale School of Medicine
New Haven, Connecticut, United States
Disclosure(s): Contract Research: achilles therapeutics (Ongoing); CRISPR Therapeutics (Ongoing); Iovance (Ongoing)
Non-CE Consulting: affini-T (Terminated, June 3, 2023); CRISPR Therapeutics (Terminated, June 3, 2023); Exelixis (Terminated, June 3, 2023); Janssen (Terminated, June 3, 2023); Pliant Therapeutics (Terminated, June 3, 2023); Regeneron (Terminated, June 3, 2023); Tscan (Terminated, June 3, 2023)